Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.

Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One. 2012; 7(4):e34833.

View in: PubMed

subject areas

Apoptosis
Dose-Response Relationship, Drug
Fatty Acids, Monounsaturated
Gene Expression Profiling
Gene Transfer Techniques
Genetic Therapy
Humans
Lung Neoplasms
Maximum Tolerated Dose
Nanoparticles
Plasmids
Positron-Emission Tomography
Quaternary Ammonium Compounds
Reverse Transcriptase Polymerase Chain Reaction
Tumor Suppressor Proteins

authors with profiles

Rajagopal Ramesh